NC
MRTX

NinePointTwo Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

NinePointTwo Capital’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,652
Closed -$240K – 338
2023
Q2 		$240K Buy
+6,652
New +$240K 0.09% 150
2022
Q3 		– Sell
-6,860
Closed -$460K – 233
2022
Q2 		$460K Buy
+6,860
New +$460K 0.16% 36